ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

This study is currently recruiting participants.
Verified by E-DA Hospital, November 2006

Sponsored by: E-DA Hospital
Information provided by: E-DA Hospital
ClinicalTrials.gov Identifier: NCT00395616
  Purpose

Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.


Condition Intervention
Type A Botulinum Toxin
Tennis Elbow
 Drug: Botox (drug)

MedlinePlus related topics:   Elbow Injuries and Disorders   

ChemIDplus related topics:   Corticosteroids    Clostridium botulinum toxin   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment

Further study details as provided by E-DA Hospital:

Primary Outcome Measures:
  • WHOQOL-BREF
  • visual analogue scale for pain
  • grip strength

Estimated Enrollment:   40
Study Start Date:   November 2006

  Eligibility
Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Pain at the lateral epicondyle of the elbow
  • Tenderness at the lateral epicondyle of the elbow
  • Pain on resisted extension of the wrist

Exclusion Criteria:

  • Local injection of steroid within 3 months
  • Previous elbow trauma or operations
  • Pregnancy
  • Systemic neuromuscular disorders such as myasthenia gravis
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00395616

Contacts
Contact: Yu-Ching Lin, MD     886-7-6150011 ext 2367     yuchinglin2003@yahoo.com.tw    

Locations
Taiwan
E-Dah Hospital     Recruiting
      Kaohsiung,, Taiwan, 833
      Contact: Yu-Ching Lin, MD     886-7-6150011 ext 2367     yuchinglin2003@yahoo.com.tw    

Sponsors and Collaborators
E-DA Hospital

Investigators
Study Chair:     Yu-Ching Lin, MD     E-Dah Hospital, Kaohsiung, Taiwan    
  More Information

Study ID Numbers:   e120537192
First Received:   November 2, 2006
Last Updated:   November 2, 2006
ClinicalTrials.gov Identifier:   NCT00395616
Health Authority:   Taiwan: Department of Health

Study placed in the following topic categories:
Botulinum Toxins
Musculoskeletal Diseases
Tennis Elbow
Wounds and Injuries
Disorders of Environmental Origin
Botulinum Toxin Type A
Arm Injuries

ClinicalTrials.gov processed this record on September 05, 2008

U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers